Goldman Sachs Group Inc ENLIVEN THERAPEUTICS INC Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024
Number of Shares
121,785
Previous 65,753 85.22%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
N/A
56,032 Added 85.22%
121,785 $0
Q2 2024

Aug 13, 2024
BUY
N/A
48,480 Added 280.67%
65,753 $0
Q1 2024

May 15, 2024
SELL
N/A
-5,425 Reduced 23.9%
17,273 $0
Q4 2023

Feb 13, 2024
BUY
N/A
5,008 Added 28.31%
22,698 $0
Q3 2023

May 14, 2024
SELL
N/A
-5,008 Reduced 22.06%
17,690 $0
Q3 2023

Nov 14, 2023
SELL
N/A
-9,596 Reduced 35.17%
17,690 $0
Q2 2023

May 14, 2024
SELL
N/A
-14,125 Reduced 34.11%
27,286 $0
Q2 2023

Aug 14, 2023
SELL
N/A
-14,125 Reduced 34.11%
27,286 $0
Q1 2023

May 14, 2024
BUY
N/A
18,713 Added 82.44%
41,411 $0
Q1 2023

May 11, 2023
BUY
N/A
41,411 New
41,411 $0
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email